On Friday, Nuvation Bio Inc (NYSE: NUVB) was -0.40% drop from the session before settling in for the closing price of $2.51. A 52-week range for NUVB has been $1.54 – $3.97.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -49.14% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 69.19%. With a float of $226.12 million, this company’s outstanding shares have now reached $338.84 million.
In an organization with 220 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 14.06%, operating margin of -5762.82%, and the pretax margin is -5534.21%.
Nuvation Bio Inc (NUVB) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Nuvation Bio Inc stocks. The insider ownership of Nuvation Bio Inc is 33.54%, while institutional ownership is 48.59%. The most recent insider transaction that took place on Jun 18 ’25, was worth 17,100. In this transaction CHIEF PEOPLE OFFICER of this company bought 10,000 shares at a rate of $1.71, taking the stock ownership to the 29,591 shares. Before that another transaction happened on Jun 17 ’25, when Company’s Chief Financial Officer bought 4,000 for $1.79, making the entire transaction worth $7,160. This insider now owns 9,902 shares in total.
Nuvation Bio Inc (NUVB) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 69.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.04% during the next five years compared to -49.14% drop over the previous five years of trading.
Nuvation Bio Inc (NYSE: NUVB) Trading Performance Indicators
You can see what Nuvation Bio Inc (NUVB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 77.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.34, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.59 in one year’s time.
Technical Analysis of Nuvation Bio Inc (NUVB)
Let’s dig in a bit further. During the last 5-days, its volume was 4.57 million. That was better than the volume of 4.2 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 85.39%.
During the past 100 days, Nuvation Bio Inc’s (NUVB) raw stochastic average was set at 81.36%, which indicates a significant increase from 79.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.15 in the past 14 days, which was lower than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.18, while its 200-day Moving Average is $2.31. However, in the short run, Nuvation Bio Inc’s stock first resistance to watch stands at $2.56. Second resistance stands at $2.62. The third major resistance level sits at $2.67. If the price goes on to break the first support level at $2.45, it is likely to go to the next support level at $2.40. Assuming the price breaks the second support level, the third support level stands at $2.34.
Nuvation Bio Inc (NYSE: NUVB) Key Stats
There are 340,263K outstanding shares of the company, which has a market capitalization of 850.66 million. As of now, sales total 7,870 K while income totals -567,940 K. Its latest quarter income was 3,080 K while its last quarter net income were -53,240 K.
